Investors naturally want to know everything about Neuralink stock because it's a headline-grabbing start-up founded by Elon Musk. The medical device company specializes in brain-computer interface technology that potentially has far-reaching applications.
A device is physically inserted into the brain to read signals and make them available for computers -- this is called "electrophysiological recording" in the trade. The technology isn't new, and multiple companies have performed human trials in the past with varying degrees of success. That said, Neuralink's design decisions could advance the technology.
Neuralink's medical device is called the N1. According to Musk, Neuralink initially aims to restore mobility in people with paraplegia, and it aims to restore vision in the sight-impaired. In short, the N1 device could be a medical breakthrough that benefits millions of people.
In early 2024, Neuralink performed its first human trial on a patient with paraplegia. In September 2025, the company announced that 12 people have received an implant.
Is Neuralink publicly traded?
Neuralink is not publicly traded. When businesses go public, they offer shares to retail investors on stock exchanges either through an initial public offering (IPO) or a direct listing. But Neuralink hasn't done either as of this writing.
To be clear, private companies like Neuralink can still have a share structure. Founders, insiders, and private investors can all own pieces of the business, and this is true of Neuralink.
Neuralink has done several funding rounds, most recently in June 2025 when it raised $650 million from investment firms in a Series E funding round. These private investors now own shares of Neuralink, although Musk, as the founder, is still believed to be the largest shareholder.
Occasionally, Neuralink shares trade hands in private transactions. However, only accredited investors can participate in these trades.
IPO
When will Neuralink IPO?
There hadn't been any formal announcements regarding the timing of a Neuralink IPO as of late 2025, so it's not on the IPO calendar. But it's fair to assume that it won't go public anytime soon.
Consider another private company owned by Musk: SpaceX. According to estimates, SpaceX is now reportedly valued at more than $400 billion, and Musk still has no plans to take it public. Neuralink is much smaller, reportedly valued closer to $9 billion as of its latest funding round. Since there aren't yet plans to take SpaceX public, its safe to assume the same with Neuralink.
When Neuralink finally decides to go public, it won't come as a total surprise. IPO stocks file paperwork with the Securities and Exchange Commission (SEC) before offering shares to the public, so investors will be aware of any Neuralink IPO before it happens.
How to buy Neuralink stock
As mentioned, regular investors can't buy Neuralink stock until it goes public. But here are some ideas for those desperate to invest in the startup.
1. Invest in Alphabet stock
Buying shares of tech titan Alphabet (GOOG -1.56%)(GOOGL -1.65%) may be the best indirect way to invest in Neuralink. The company has its own venture capital arm called Google Ventures, which is an early investor in Neuralink.
Given its stake in the startup, Neuralink technically comprises a part of Alphabet. That said, it's a minuscule stake compared to the overall size of Alphabet's business.
2. Invest in Tesla stock
Getting a stake in Neuralink by investing in Tesla (TSLA -0.01%) stock is an immensely speculative long shot, at best. In 2022, an analyst asked Musk if he would ever consider lumping all of his companies, including Tesla and Neuralink, into one publicly traded entity. Musk said he was unsure and that he saw no reason to combine the companies soon.
It seems incredibly unlikely that Neuralink and Tesla would ever be housed under one parent company. But Musk didn't completely rule it out when directly asked.
3. Just wait for Neuralink stock
As can be seen, investing in Neuralink stock is basically impossible at this stage of the game. But for investors who still want to invest directly in Neuralink, the last option is simply to wait for a future IPO.
Buying stocks step-by-step
To buy Alphabet, Tesla, or a future Neuralink IPO, investors will need to follow a few steps.
- Open your brokerage account: Log in to your brokerage account where you handle your investments.
- Search for the stock: Enter the ticker or company name into the search bar to bring up the stock's trading page.
- Decide how many shares to buy: Consider your investment goals and how much of your portfolio you want to allocate to this stock.
- Select order type: Choose between a market order to buy at the current price or a limit order to specify the maximum price you're willing to pay.
- Submit your order: Confirm the details and submit your buy order.
- Review your purchase: Check your portfolio to ensure your order was filled as expected and adjust your investment strategy accordingly.
Is Neuralink profitable?
Neuralink is a private company, and its financials aren't publicly available. That said, it's very safe to assume that the company is not profitable.
Losses are common among medical device start-up companies. These businesses have to build out a technology and demonstrate its effectiveness before commercialization can begin. It's a stage in which companies such as Neuralink spend tons of money on research and development, as well as on sales and marketing. And during this phase, the company has almost no revenue because it has few (if any) customers.
While trials are expected to accelerate in the coming years after starting in 2024, they will likely generate minimal revenue, at best, and will likely be unprofitable -- the early-stage goal is proof of concept. Only after years of successful trials would the business have an opportunity to be profitable.
Should I invest in Neuralink?
Investment decisions are personal, but it can be OK to invest in a speculative company like Neuralink. Indeed, the company is promising to solve enormous problems, and big ideas like this can often lead to game-changing investment gains.
However, more often than not, speculative investment ideas don't work out and lead to big losses. Sometimes, speculative companies even go out of business entirely, leaving investors with nothing.
Neuralink isn't public yet. But if it goes public, investors will need to recognize how risky it would be to invest at this stage of its business.
Exchange-Traded Fund (ETF)
ETFs with exposure to Neuralink
I'm not aware of any exchange-traded funds (ETFs) that have direct exposure to Neuralink. That said, Neuralink is advancing robotic surgery. Musk has also said that the company's long-term goal is to reduce the risk from artificial intelligence (AI).
But for investors interested in Neuralink stock because they like the themes of robotic surgery and AI, The Global X Robotics & Artificial Intelligence ETF (BOTZ +0.23%) may be one to consider. Top stocks in this ETF include Nvidia (NVDA +1.50%) and Intuitive Surgical (ISRG -1.06%).
This is just speculation, but if Neuralink really can restore mobility and vision, then other players in this field would likely emerge focusing on different problems. Consider that prominent billionaires Jeff Bezos and Bill Gates have both invested in Synchron, a Neuralink peer.
A company like Intuitive Surgical, for example, may eventually be in a position to benefit from new trends pushed forward by advances in brain-computer interface technology. But that's likely still years away.
Related investing topics
The bottom line on Neuralink
Neuralink believes it can restore lost mobility and vision through its brain-computer interface technology. These are big issues that could potentially make Neuralink a big business in the future.
However, for now, the company isn't public, so investors can't buy stock. Even if it were public, it would still be a speculative investment opportunity, and shareholders would need a healthy appreciation of risk.
FAQ
About the Author
